Safety assessment of the candidate oral probiotic Lactobacillus crispatus YIT 12319: Analysis of antibiotic resistance and virulence-associated genes.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 03 09 2019
revised: 02 03 2020
accepted: 15 03 2020
pubmed: 27 3 2020
medline: 20 2 2021
entrez: 27 3 2020
Statut: ppublish

Résumé

Lactobacillus crispatus YIT 12319 (LcY) was isolated from the oral cavity of a healthy subject as a new candidate probiotic with potential benefits for oral health. As a safety assessment of LcY, we performed an antibiotic susceptibility test and virulence-associated gene analysis using a draft genome sequence. Susceptibility to 15 antibiotics was analyzed according to the standard method of the International Dairy Federation/International Organization for Standardization, as recommended by the European Food Safety Authority. The results showed that the minimum inhibitory concentrations of LcY were not higher than those of other L. crispatus strains, which have not acquired resistance to any antibiotics, suggesting that LcY had no externally acquired transmissible antibiotic resistance genes. Analysis of virulence-associated genes using the draft genome of LcY found that there were fewer potential virulence-associated genes in LcY than in other probiotics. These findings suggest that LcY could be a candidate probiotic based on its safety profile.

Identifiants

pubmed: 32209355
pii: S0278-6915(20)30166-6
doi: 10.1016/j.fct.2020.111278
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111278

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This work was funded by the Yakult Central Institute (http://institute.yakult.co.jp/). The funder provided support in the form of salaries for the authors (TT, KK, EI, MN, MI, KM, AK, and TO), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SI, YN, and NH received research funds from the Yakult Central Institute.

Auteurs

Tomohiko Terai (T)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan. Electronic address: tomohiko-terai@yakult.co.jp.

Kosuke Kato (K)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Eiji Ishikawa (E)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Masumi Nakao (M)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Masahiko Ito (M)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Kouji Miyazaki (K)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Akira Kushiro (A)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Susumu Imai (S)

Department of Translational Research, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Kanagawa, 230-8501, Japan.

Yoshiaki Nomura (Y)

Department of Translational Research, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Kanagawa, 230-8501, Japan.

Nobuhiro Hanada (N)

Department of Translational Research, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Kanagawa, 230-8501, Japan.

Takekazu Okumura (T)

Yakult Central Institute, 5-11 Izumi, Kunitachi, Tokyo, 186-8650, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH